Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

• Main Authors: Anna H. Tran, Brookie M. Best, Alice Stek, Jiajia Wang, Edmund V. Capparelli, Sandra K. Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Kathleen George, Tim R. Cressey, Nahida Chakhtoura, Elizabeth Smith, David E. Shapiro, Mark Mirochnick, Shelley Buschur, Chivon Jackson, Mary Paul, Donna McGregor, Ram Yogev, Rohit Kalra, Claudia Florez, Patricia Bryan, Monica Stone, Andrew D. Hull, Mary Caffery, Stephen A. Spector, Joan Wilson, Julieta Giner, Margaret A. Donnelly, Ellen R. Cooper, Debra A. McLaud, Lisa F. Tucker, Jane Hitti, Amanda Robson-Nuss, Ann J. Melvin, Margaret A. Keller, Michael A. Bolaris, Judy Hayes, Françoise Kamer, La Shonda Spencer, James Homans, Torri Metz, Jenna Wallace, Alisa Katai, Mariam Aziz, Maureen McNichols, Julie Schmidt, Diane Wara, Kristinalisa Maka, Deborah Cohan, Audra Deveikis, Jagmohan Batra, Janielle Jackson Alvarez, Michele Carter, Jaime Deville, Carla Janzen, Jenny Gutierrez, Martha Cavallo, Murli Purswani, Katherine M. Knapp, Nina Sublette, Thomas Wride
• 格式: 雜誌
• 出版: 2018
• 主題: Medicine
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959196606&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/56125
• 機構: Chiang Mai University

© Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. Background: Rilpivirine pharmacokinetics is defined by its absorption, distribution, metabolism, and excretion. Pregnancy can affect these factors by changes in cardiac output, protein binding, volume of distribution, and cytochrome P...